Spiro Medical is developing an implantable neuromodulation system designed to address the unmet needs of patients with severe, uncontrolled asthma.
Our approach combines deep clinical insights with advanced neuromodulation technology.
Targeted spinal nerve stimulation designed to modulate respiratory function and reduce asthma symptom burden in severe cases.
Implantable device technology engineered for consistent, reliable therapeutic delivery at the thoracic spinal level.
Evidence-based approach supported by renowned experts and advancing through structured clinical trials.
Severe asthma represents a complex clinical challenge affecting approximately 5–10% of all asthma patients. Despite optimized pharmacological therapy, many patients continue to experience significant symptom burden, frequent exacerbations that can be life-threatening, and reduced quality of life.
Current treatment options, while valuable, may not adequately address the underlying neurological components of respiratory regulation. Neuromodulation offers a promising complementary therapeutic approach by targeting autonomic nervous system pathways that influence bronchial tone and inflammatory responses.
Spiro Medical's investigational therapy is designed to provide a novel intervention for patients who have exhausted conventional treatment options.
Explore collaboration opportunities, investment inquiries, or learn more about our clinical development program.